TerminatedPhase 4

Comparison Between 4 Different Nasal Dilators

Stopped: No contract, no costs

Belgium100 participantsStarted 2014-01

Plain-language summary

Several nasal dilators are currently commercially available, and can be applied endonasally (Airmax°, Nozovent and Nasanita°) or externally (Breath Right°). An objective comparison between these dilators has not been made so far, and would help the clinicians to advise the use of any of these dilators. From clinical experience, endonasal dilators are well supported and improve breathing better than the external dilators

Who can participate

Age range18 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Patients with nasal obstruction due to external nasal valve problems and with positive Cottle sign. Age \> 18 and \< 60 years. Ability to give reliable information and written informed consent. Exclusion Criteria: Patients with nasal obstruction due to other endonasal anatomic deformities besides external nasal valve dysfunction. Patients with rhinosinusitis and/or nasal polyps evaluated by nasal endoscopy. Patients with chronic lower airway disease like severe asthma, chronic obstructive pulmonary disease (COPD), bronchiectasis and/or other conditions that interfere with the generation of a reliable Peak Nasal Inspiratory Flow (PNIF) result.

What they're measuring

Peak Nasal Inflammatory Flow

Timeframe: 4 weeks

Trial details

NCT IDNCT02196389

SponsorUniversitaire Ziekenhuizen KU Leuven

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-08-18

View on ClinicalTrials.gov More Incompetence of Nasal Valve trials